328 related articles for article (PubMed ID: 26171776)
1. Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.
Martins LJ; Bonczkowski P; Spivak AM; De Spiegelaere W; Novis CL; DePaula-Silva AB; Malatinkova E; Trypsteen W; Bosque A; Vanderkerckhove L; Planelles V
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):187-93. PubMed ID: 26171776
[TBL] [Abstract][Full Text] [Related]
2. Modeling HIV-1 Latency Using Primary CD4
Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
Banga R; Procopio FA; Cavassini M; Perreau M
J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
[TBL] [Abstract][Full Text] [Related]
4. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
5. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
Siliciano JD; Siliciano RF
Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a Novel Humanized Mouse Model To Investigate
Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
[TBL] [Abstract][Full Text] [Related]
7. LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds.
Jung U; Takahashi M; Rossi JJ; Burnett JC
Methods Mol Biol; 2016; 1354():255-64. PubMed ID: 26714717
[TBL] [Abstract][Full Text] [Related]
8. Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.
Macedo AB; Resop RS; Martins LJ; Szaniawski MA; Sorensen ES; Spivak AM; Nixon DF; Jones RB; Planelles V; Bosque A
AIDS Res Hum Retroviruses; 2018 Sep; 34(9):769-777. PubMed ID: 29926732
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells.
Couturier J; Orozco AF; Liu H; Budhiraja S; Siwak EB; Nehete PN; Sastry KJ; Rice AP; Lewis DE
Virol J; 2019 Feb; 16(1):22. PubMed ID: 30786885
[TBL] [Abstract][Full Text] [Related]
10. A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.
Lassen KG; Hebbeler AM; Bhattacharyya D; Lobritz MA; Greene WC
PLoS One; 2012; 7(1):e30176. PubMed ID: 22291913
[TBL] [Abstract][Full Text] [Related]
11. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
12. Infection with a newly designed dual fluorescent reporter HIV-1 effectively identifies latently infected CD4
Cai J; Gao H; Zhao J; Hu S; Liang X; Yang Y; Dai Z; Hong Z; Deng K
Elife; 2021 Apr; 10():. PubMed ID: 33835029
[TBL] [Abstract][Full Text] [Related]
13. Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro post-integration latency models.
Bonczkowski P; De Scheerder MA; Malatinkova E; Borch A; Melkova Z; Koenig R; De Spiegelaere W; Vandekerckhove L
Sci Rep; 2016 Dec; 6():38329. PubMed ID: 27910923
[TBL] [Abstract][Full Text] [Related]
14. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
Krishnan V; Zeichner SL
J Virol; 2004 Sep; 78(17):9458-73. PubMed ID: 15308739
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.
White CH; Moesker B; Beliakova-Bethell N; Martins LJ; Spina CA; Margolis DM; Richman DD; Planelles V; Bosque A; Woelk CH
PLoS Pathog; 2016 Nov; 12(11):e1006026. PubMed ID: 27898737
[TBL] [Abstract][Full Text] [Related]
16. Higher expression of human telomerase reverse transcriptase in productively-infected CD4 cells possibly indicates a mechanism for persistence of the virus in HIV infection.
Suryawanshi P; Godbole S; Pawar J; Thakar M; Shete A
Microbiol Immunol; 2018 May; 62(5):317-326. PubMed ID: 29577368
[TBL] [Abstract][Full Text] [Related]
17. Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.
Persaud D; Ray SC; Kajdas J; Ahonkhai A; Siberry GK; Ferguson K; Ziemniak C; Quinn TC; Casazza JP; Zeichner S; Gange SJ; Watson DC
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):381-90. PubMed ID: 17411371
[TBL] [Abstract][Full Text] [Related]
18. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD; Moore B; Cloyd MW
Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals.
Fondere JM; Petitjean G; Huguet MF; Salhi SL; Baillat V; Macura-Biegun A; Becquart P; Reynes J; Vendrell JP
J Virol; 2004 Oct; 78(19):10536-42. PubMed ID: 15367620
[TBL] [Abstract][Full Text] [Related]
20. Entry of Polarized Effector Cells into Quiescence Forces HIV Latency.
Dobrowolski C; Valadkhan S; Graham AC; Shukla M; Ciuffi A; Telenti A; Karn J
mBio; 2019 Mar; 10(2):. PubMed ID: 30914509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
